Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Clume Health vs Lean Rx

Clume Health
Graded #265

Higher grade

vs+3.1
Lean Rx
Graded #346

Lower grade

The verdict

Clume Health takes it — 63.7/100 to 60.6/100.

Clume Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Clume Health charges one price for either molecule in either form, and advertises two hero figures on its homepage that match nothing it sells.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLean Rx +2
38
40
Dose & formulationEven
75
75
Clinical oversightLean Rx +11
70
81
Labs & monitoringEven
52
52
FulfillmentClume Health +28
88
60
Contract termsClume Health +30
85
55
Clume Health · left barLean Rx · right bar

The numbers

MetricClume HealthLean Rx
WeighScore63.7/10060.6/100
GradeCC
Scorecard rank#265#346
Semaglutide$259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan)$266/mo (starting dose, compounded)
Tirzepatide$259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan)$399/mo (starting dose, compounded)
CoverageAll 50 states plus Washington, D.C.Coverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Clume Health

Graded #265 · C

Strengths

  • One Signature price covers semaglutide or tirzepatide, injectable or oral, so switching molecule or route does not change the bill
  • A separate microdose and maintenance program is priced on its own at $219 a month rather than sold as a discount on the main line
  • Names four dispensing pharmacies with street addresses and phone numbers, which is more than most of the field publishes
  • States service in all 50 states plus Washington, D.C. without contradicting itself elsewhere
  • A full refund is available if the subscription is canceled within the first 72 hours and before the medication ships

Where it loses points

  • Neither homepage hero price matches anything sold: $199 a month is advertised against real floors of $259 and $219, and $159 against a figure of $216 that itself needs a 12-week plan
  • Both hero prices carry an asterisk that resolves to no footnote anywhere on the page
  • The cheaper monthly figures are commitments — $186 needs 52 weeks and $200 needs 12 — printed on the same card as the month-to-month rate
  • The refund policy promises a 24/7 patient support line and no phone number appears anywhere on the site; support is email only
  • Whether the medication is compounded, and under 503A or 503B, is never stated
  • No clinician is named. The Terms name only “the OpenLoop Medical Practices”, with no individual, no NPI and no medical group entity
Lean Rx

Graded #346 · C

Strengths

  • Both semaglutide and tirzepatide offered
  • Three formulations: injectable, sublingual, and tablet
  • Upfront pricing with no hidden fees advertised
  • Semaglutide starts at a low $266/month
  • Telehealth call with a licensed provider before prescribing

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • Platform is technology only, not a healthcare provider itself
  • Provider credentials not detailed on site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard